高级搜索
促凋亡蛋白Bim在肺癌中的研究进展[J]. 肿瘤防治研究, 2014, 41(11): 1247-1250. DOI: 10.3971/j.issn.1000-8578.2014.11.019
引用本文: 促凋亡蛋白Bim在肺癌中的研究进展[J]. 肿瘤防治研究, 2014, 41(11): 1247-1250. DOI: 10.3971/j.issn.1000-8578.2014.11.019
Pro-apoptotic Protein Bim in Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(11): 1247-1250. DOI: 10.3971/j.issn.1000-8578.2014.11.019
Citation: Pro-apoptotic Protein Bim in Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(11): 1247-1250. DOI: 10.3971/j.issn.1000-8578.2014.11.019

促凋亡蛋白Bim在肺癌中的研究进展

Pro-apoptotic Protein Bim in Lung Cancer

  • 摘要: Bim是Bcl-2家族中仅含一个BH3结构域的蛋白,具有促凋亡活性。Bim的功能调节包括转录和翻译后两个水平。Bim在抗微管药物诱导肺癌细胞和酪氨酸激酶抑制剂(tyrosine kinase inhibitors, TKIs)诱导表皮生长因子受体突变的非小细胞肺癌细胞凋亡过程中起重要作用。BH3结构模拟肽、BCL-2抑制剂以及与TKIs联合使用有望克服肺癌治疗中Bim引起的耐药问题。本文将对Bim结构与功能、作用机制与调节以及在肺癌化疗与TKIs治疗中的研究进展进行综述。

     

    Abstract: Bim, a member of Bcl-2 family, contains only a BH3 domain and has pro-apoptotic function. The regulations of Bim include translation and post-translation. Bim plays an important role in cell apoptosis, including both the anti-tuber induced lung cancer cells and tyrosine kinase inhibitors(TKIs) induced nonsmall cell lung cancer cells with epidermal growth factor receptor(EGFR) mutation. The combination of BH3-mimetic drugs, BCL-2 inhibitors and TKIs may overcome the resistant problems caused by Bim. This review aims to summarise the struction and function, mechanism and regulation of Bim, as well as the progression of chemotherapy and TKIs treatment in lung cancers.

     

/

返回文章
返回